欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4776/004
药品名称Flucloxacillin Kabi 2000 mg poeder voor oplossing voor injectie/ infusie
活性成分
    • flucloxacillin sodium salt 2000.0 mg
剂型Powder for solution for injection/infusion
上市许可持有人Fresenius Kabi
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
      Flucloxacillin Kabi 2000 mg Pulver zur Herstellung einer Injektions-/Infusionslösung
    • Belgium (BE)
      Flucloxacilline Fresenius Kabi 2000 mg poeder voor oplossing voor injectie/infusie
    • Ireland (IE)
    • Austria (AT)
      Flucloxacillin Kabi 2000 mg Pulver zur Herstellung einer Injektions-/Infusionslösung
    • Portugal (PT)
    • Czechia (CZ)
      Flucloxacillin Fresenius Kabi
    • Slovakia (SK)
      Flucloxacillin Fresenius Kabi 2 g
    • Slovenia (SI)
许可日期2020/09/03
最近更新日期2024/05/21
药物ATC编码
    • J01CF05 flucloxacillin
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase